![](https://img.group-telegram.com/icon/me/medpartsarp.jpg)
Medpart SARP Telegram | DID YOU KNOW?
Date: | Medpart SARP
Since January 2022, the SC has received a total of 47 complaints and enquiries on illegal investment schemes promoted through Telegram. These fraudulent schemes offer non-existent investment opportunities, promising very attractive and risk-free returns within a short span of time. They commonly offer unrealistic returns of as high as 1,000% within 24 hours or even within a few hours. The regulator said it has been undertaking several campaigns to educate the investors to be vigilant while taking investment decisions based on stock tips. Additionally, investors are often instructed to deposit monies into personal bank accounts of individuals who claim to represent a legitimate entity, and/or into an unrelated corporate account. To lend credence and to lure unsuspecting victims, perpetrators usually claim that their entity and/or the investment schemes are approved by financial authorities. Investors took profits on Friday while they could ahead of the weekend, explained Tom Essaye, founder of Sevens Report Research. Saturday and Sunday could easily bring unfortunate news on the war front—and traders would rather be able to sell any recent winnings at Friday’s earlier prices than wait for a potentially lower price at Monday’s open. Ukrainian forces have since put up a strong resistance to the Russian troops amid the war that has left hundreds of Ukrainian civilians, including children, dead, according to the United Nations. Ukrainian and international officials have accused Russia of targeting civilian populations with shelling and bombardments.
Medpart SARP from id
Medpart SARP
group-telegram.com/medpartsarp
Russia RU telegram Group & telegram Channel 10
![](https://img.group-telegram.com/icon/me/medpartsarp.jpg)
Created:
From: Russia and American
Telegram Medpart SARP, 399660 Telegram Group & Telegram Channel Russia, RUTelegram Medpart SARP, 399660 Telegram Group & Telegram Channel, American, US
https://t.me/medpartsarp
Webview